Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
ACTH hypertension in the rat: role of sodium chloride.
|
1321011 |
1992 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Children who develop hypertension during ACTH therapy should be considered at risk for hypertrophic cardiomyopathy and should undergo routine echocardiographic evaluation.
|
2821097 |
1987 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
The role of the parathyroid glands in adrenocorticotrophin-induced hypertension in the rat.
|
10513829 |
1999 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
This result indicates that the cardiac glycoside binding site of the alpha1 isoform can also mediate ACTH-induced hypertension.
|
16243970 |
2005 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Changes in pressor responsiveness do not explain ACTH hypertension.
|
3015460 |
1986 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Circadian blood pressure variability in adrenocorticotrophin-induced hypertension in the rat.
|
11518849 |
2001 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants.
|
2551692 |
1989 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
In man ACTH produces systolic hypertension which can be reproduced by infusion of cortisol, but not deoxycorticosterone, at rates appropriate for conditions of ACTH stimulation.
|
3001556 |
1985 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Role of the renal medulla in adrenocorticotrophin-induced hypertension in rats.
|
1334993 |
1992 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat.
|
10658937 |
1999 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Nitric oxide synthase activity in adrenocorticotrophin-induced hypertension in the rat.
|
11703388 |
2001 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
The role of this increased pressor responsiveness in ACTH/steroid-induced hypertension remains to be determined.
|
1321309 |
1992 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
BEFREE |
Analyses of aldosterone/PRA/cortisol 'day-curves' have revealed that (1) the hybrid gene dominates over wild type CYP11B2 in terms of aldosterone regulation and (2) correction of hypertension in FH-I requires only partial suppression of ACTH, and much smaller glucocorticoid doses than those previously recommended.
|
11595502 |
2001 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Adrenocorticotrophin-induced hypertension in rats. Role of progesterone and digoxin-like substances.
|
8136112 |
1994 |
Hypertensive disease
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity.
|
26103132 |
2015 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Alterations in osmotic but not pressor responses to ACTH by optic recess lesions in sheep.
|
6279500 |
1982 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
We hypothesized that ACTH-induced hypertension in the rat is characterized by increased EPO production.
|
15110907 |
2004 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
BEFREE |
Identifying the mechanism of ACTH-dependent proliferation of VSMCs may help to provide new therapeutic targets for hypertension.
|
29943847 |
2018 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Corticotropin effects on blood pressure and fluid and electrolyte homeostasis in five strains of rats.
|
1316127 |
1992 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Thus, NAC partially prevented but did not reverse ACTH-induced hypertension.
|
16546835 |
2006 |
Hypertensive disease
|
0.400 |
AlteredExpression
|
group |
BEFREE |
In this review we discuss the importance of the brain POMC-MC4R system in regulating SNS activity and BP in obesity and other forms of hypertension.
|
28274841 |
2017 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
However, when RAP is not allowed to rise, ACTH is associated with sodium retention and severe systemic hypertension, suggesting that the natriuretic effects of ACTH are caused by increased RAP and that the natriuresis blunts the chronic hypertensive effects of ACTH.
|
2849322 |
1988 |
Hypertensive disease
|
0.400 |
Therapeutic
|
group |
CTD_human |
Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.
|
15554453 |
2004 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats.
|
17994356 |
2007 |
Hypertensive disease
|
0.400 |
Biomarker
|
group |
CTD_human |
L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat.
|
11193135 |
2000 |